Cellular immunology · 2011
The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Amir Jamie, Waite Matthew, Tobler Jeffrey, Catalfamo Dana L, Koutouzis Theofilos, Katz Joseph, Wallet Shannon M
Аннотация
Immune modulating factors are necessary for pathogen clearance, but also contribute to host tissues damage, as those seen in periodontal diseases. Many of these responses can be exacerbated by host conditions including type 2 diabetes [T2D], where toll-like receptor 4 [TLR4] and the receptor for advanced glycated end products [RAGE] play a significant role. Here we investigate causality associated with the increase in inflammatory markers observed in periodontally diseased patients with T2D using multi-variant correlation analysis. Inflammation associated with periodontal diseases, characterized by elevated pro-inflammatory cytokines, innate immune receptor expression, and cellular infiltrate was exacerbated in patients with T2D. In addition, a feed forward loop regulated by poor glycemic control was associated with a loss of mucosal barrier integrity and accumulation of innate immune receptor ligands resulting in an exacerbation of ongoing inflammation, where RAGE and TLR4 cooperated to induce responses in oral epithelial cells, which were exacerbated by hyperglycemia.
Предметные рубрики MeSH
AdolescentAdultAgedCase-Control StudiesChronic PeriodontitisDiabetes Mellitus, Type 2Epithelial CellsFemaleHumansHyperglycemiaImmunity, InnateImmunity, MucosalInflammationLigandsMaleMiddle AgedMouthPrimary Cell CultureReceptor Cross-TalkReceptor for Advanced Glycation End ProductsReceptors, ImmunologicSignal TransductionToll-Like Receptor 4